| Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation S Copsel, C Garcia, F Diez, M Vermeulem, A Baldi, LG Bianciotti, ... Journal of biological chemistry 286 (9), 6979-6988, 2011 | 195 | 2011 |
| Marked in vivo donor regulatory T cell expansion via interleukin-2 and TL1A-Ig stimulation ameliorates graft-versus-host disease but preserves graft-versus-leukemia in … D Wolf, H Barreras, CS Bader, S Copsel, CO Lightbourn, BJ Pfeiffer, ... Biology of blood and marrow transplantation 23 (5), 757-766, 2017 | 48 | 2017 |
| Differential β2-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines L Gargiulo, S Copsel, EM Rivero, C Galés, JM Sénard, IA Lüthy, C Davio, ... Oncotarget 5 (20), 10058, 2014 | 42 | 2014 |
| Expression of a G protein-coupled receptor (GPCR) leads to attenuation of signaling by other GPCRs: experimental evidence for a spontaneous GPCR constitutive inactive form MR Tubio, N Fernandez, CP Fitzsimons, S Copsel, S Santiago, C Shayo, ... Journal of biological chemistry 285 (20), 14990-14998, 2010 | 40 | 2010 |
| Multidrug resistance protein 4/ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia S Copsel, A Bruzzone, M May, J Beyrath, V Wargon, J Cany, GMR Frans, ... Oncotarget 5 (19), 9308, 2014 | 38 | 2014 |
| A novel effect of β-adrenergic receptor on mammary branching morphogenesis and its possible implications in breast cancer L Gargiulo, M May, EM Rivero, S Copsel, C Lamb, J Lydon, C Davio, ... Journal of mammary gland biology and neoplasia 22, 43-57, 2017 | 26 | 2017 |
| The promise of CD4+ FoxP3+ regulatory T-cell manipulation in vivo: applications for allogeneic hematopoietic stem cell transplantation S Copsel, D Wolf, KV Komanduri, RB Levy Haematologica 104 (7), 1309, 2019 | 22 | 2019 |
| Very low numbers of CD4+ FoxP3+ tregs expanded in donors via TL1A-Ig and low-dose IL-2 exhibit a distinct activation/functional profile and suppress GVHD in a preclinical model S Copsel, D Wolf, B Kale, H Barreras, CO Lightbourn, CS Bader, ... Biology of blood and marrow transplantation 24 (9), 1788-1794, 2018 | 21 | 2018 |
| BET bromodomain inhibitors which permit treg function enable a combinatorial strategy to suppress GVHD in pre-clinical allogeneic HSCT SN Copsel, CO Lightbourn, H Barreras, I Lohse, D Wolf, CS Bader, ... Frontiers in immunology 9, 3104, 2019 | 20 | 2019 |
| Superior immune reconstitution using Treg-expanded donor cells versus PTCy treatment in preclinical HSCT models D Wolf, CS Bader, H Barreras, S Copsel, BJ Pfeiffer, CO Lightbourn, ... JCI insight 3 (20), 2018 | 19 | 2018 |
| Atrial natriuretic factor stimulates efflux of cAMP in rat exocrine pancreas via multidrug resistance–associated proteins MR Rodríguez, F Diez, MS Ventimiglia, V Morales, S Copsel, MS Vatta, ... Gastroenterology 140 (4), 1292-1302, 2011 | 18 | 2011 |
| Histamine H2 Receptor in Blood Cells: A Suitable Target for the Treatment of Acute Myeloid Leukemia F Monczor, S Copsel, N Fernandez, C Davio, C Shayo Histamine and Histamine Receptors in Health and Disease, 141-160, 2017 | 17 | 2017 |
| STING differentially regulates experimental GVHD mediated by CD8 versus CD4 T cell subsets CS Bader, H Barreras, CO Lightbourn, SN Copsel, D Wolf, J Meng, J Ahn, ... Science translational medicine 12 (552), eaay5006, 2020 | 15 | 2020 |
| Medical treatment can unintentionally alter the regulatory T-cell compartment in patients with widespread pathophysiologic conditions SN Copsel, TR Malek, RB Levy The American journal of pathology 190 (10), 2000-2012, 2020 | 7 | 2020 |
| Use of post-transplant cyclophosphamide treatment to build a tolerance platform to prevent liquid and solid organ allograft rejection CO Lightbourn, D Wolf, SN Copsel, Y Wang, BJ Pfeiffer, H Barreras, ... Frontiers in immunology 12, 636789, 2021 | 4 | 2021 |
| IL-2/IL-2R, TL1A/TNFRSF25 or their combined stimulation results in distinct CD4+ FoxP3+ regulatory T cell phenotype and suppressive function SN Copsel, H Barreras, CO Lightbourn, CS Bader, D Wolf, B Kale, ... Biology of blood and marrow transplantation 26 (3), S169, 2020 | 4 | 2020 |
| Marked in vivo donor Treg expansion via IL-2 and TL1A-Ig stimulation Ameliorates GVHD but preserves GVL in recipients Post-HSCT D Wolf, H Barreras, CS Bader, S Copsel, CO Lightbourn, BJ Pfeiffer, ... Biology of blood and marrow transplantation: journal of the American Society …, 2017 | 4 | 2017 |
| Recipient Tregs: can they be exploited for successful hematopoietic stem cell transplant outcomes? SN Copsel, D Wolf, B Pfeiffer, H Barreras, VL Perez, RB Levy Frontiers in immunology 13, 932527, 2022 | 2 | 2022 |
| Improved NK cell recovery following use of PTCy or Treg expanded donors in experimental MHC-matched allogeneic HSCT D Wolf, H Barreras, SN Copsel, KV Komanduri, RB Levy Transplantation and cellular therapy 28 (6), 303. e1-303. e7, 2022 | 2 | 2022 |
| Regulatory T Cell Amelioration of Graft-versus-Host Disease following Allogeneic/Xenogeneic Hematopoietic Stem Cell Transplantation Using Mobilized Mouse and Human Peripheral … H Barreras, SN Copsel, CS Bader, Y Ding, D Wolf, C Cash, CJ Stacey, ... Transplantation and cellular therapy 29 (5), 341. e1-341. e9, 2023 | 1 | 2023 |
Krishna KomanduriProfessor and Division Chief, Unibersity of California San FranciscoVerified email at miami.edu
